162 related articles for article (PubMed ID: 33838549)
1. The in vitro effects of hepatoblastoma cells on the growth and differentiation of blasts in transient abnormal myelopoiesis associated with Down syndrome.
Miyauchi J; Kawaguchi H
Leuk Res; 2021 Jun; 105():106570. PubMed ID: 33838549
[TBL] [Abstract][Full Text] [Related]
2. Fetal liver stromal cells support blast growth in transient abnormal myelopoiesis in Down syndrome through GM-CSF.
Miyauchi J; Kawaguchi H
J Cell Biochem; 2014 Jun; 115(6):1176-86. PubMed ID: 24415393
[TBL] [Abstract][Full Text] [Related]
3. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review.
Miyauchi J
Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838
[TBL] [Abstract][Full Text] [Related]
4. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
Chisholm KM; Rivetta CV; Heerema-McKenney A
Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
[TBL] [Abstract][Full Text] [Related]
5. Expression of megakaryocytic and myeloid markers in blasts of transient abnormal myelopoiesis in a stillbirth with Down syndrome: report of histopathological findings of an autopsy case.
Ishigaki H; Miyauchi J; Yokoe A; Nakayama M; Yanagi T; Taga T; Ohta S; Itoh Y; Ogasawara K
Hum Pathol; 2011 Jan; 42(1):141-5. PubMed ID: 20970166
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
Watanabe K
Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
[TBL] [Abstract][Full Text] [Related]
7. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
Bombery M; Vergilio JA
Arch Pathol Lab Med; 2014 Oct; 138(10):1302-6. PubMed ID: 25268193
[TBL] [Abstract][Full Text] [Related]
8. Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
Miyauchi J; Ito Y; Tsukamoto K; Takahashi H; Ishikura K; Sugita K; Miyashita T
Br J Haematol; 2010 Mar; 148(6):898-909. PubMed ID: 20064153
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome.
Toki T; Kanezaki R; Kobayashi E; Kaneko H; Suzuki M; Wang R; Terui K; Kanegane H; Maeda M; Endo M; Mizuochi T; Adachi S; Hayashi Y; Yamamoto M; Shimizu R; Ito E
Blood; 2013 Apr; 121(16):3181-4. PubMed ID: 23440243
[TBL] [Abstract][Full Text] [Related]
10. Extensive placental choriovascular infiltration by maturing myeloid cells in down syndrome-associated transient abnormal myelopoiesis.
Ravishankar S; Hoffman L; Lertsburapa T; Welch J; Treaba D; De Paepe ME
Pediatr Dev Pathol; 2015; 18(3):231-6. PubMed ID: 25587735
[TBL] [Abstract][Full Text] [Related]
11. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
Bhatnagar N; Nizery L; Tunstall O; Vyas P; Roberts I
Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823
[TBL] [Abstract][Full Text] [Related]
12. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants.
Orozco-Vela M; Corona-Rivera A; Cruz-Osorio RM; Mendoza-Maldonado L; Márquez-Mora A; Barba-Barba CC; Peña-Padilla C; Baldomero-López A; Bobadilla-Morales L; Corona-Rivera JR
Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702
[TBL] [Abstract][Full Text] [Related]
13. Effects of thrombopoietin (c-mpl ligand) on growth of blast cells from patients with transient abnormal myelopoiesis and acute myeloblastic leukemia.
Hirai H; Shimazaki C; Yamagata N; Goto H; Inaba T; Kikuta T; Sumikuma T; Sudo Y; Ashihara E; Fujita N; Hibi S; Imashuku S; Ito E; Nakagawa M
Eur J Haematol; 1997 Jul; 59(1):38-46. PubMed ID: 9260579
[TBL] [Abstract][Full Text] [Related]
14. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
Roy A; Roberts I; Vyas P
Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
[TBL] [Abstract][Full Text] [Related]
15. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis.
Yumura-Yagi K; Hara J; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1994 May; 13(5-6):393-400. PubMed ID: 8069184
[TBL] [Abstract][Full Text] [Related]
17. Transient myeloproliferative disorder in neonates without Down syndrome: case report and review.
Schifferli A; Hitzler J; Bartholdi D; Heinimann K; Hoeller S; Diesch T; Kühne T
Eur J Haematol; 2015 May; 94(5):456-62. PubMed ID: 24853125
[TBL] [Abstract][Full Text] [Related]
18. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
[TBL] [Abstract][Full Text] [Related]
19. Prominent megakaryocytic dysplasia after regression of transient abnormal myelopoiesis associated with GATA-1 mutation.
Anoop P; Atra A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):640. PubMed ID: 23007419
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institution.
Yamato G; Park MJ; Sotomatsu M; Kaburagi T; Maruyama K; Kobayashi T; Nishi A; Sameshima K; Ohki K; Hayashi Y
Int J Hematol; 2021 May; 113(5):662-667. PubMed ID: 33394336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
